We are live on
!
Find out more
MPAM
Murphy Pohlad Asset Management Portfolio holdings
AUM
$287M
1-Year Est. Return
38.81%
This Fund
S&P 500
This Quarter
Est. Return
+16.13%
1 Year Est. Return
+38.81%
3 Year Est. Return
+75.1%
5 Year Est. Return
+92.69%
10 Year Est. Return
+345.48%
AUM
$202M
AUM Growth
+$13.5M
(+7.2%)
Cap. Flow
-$12M
Cap. Flow
% of AUM
-5.95%
Top 10 Holdings %
Top 10 Hldgs %
31.54%
Holding
104
New
3
Increased
12
Reduced
59
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$954K |
| 2 |
Newell Brands
NWL
|
+$454K |
| 3 |
ConocoPhillips
COP
|
+$359K |
| 4 |
General Dynamics
GD
|
+$269K |
| 5 |
Kimberly-Clark
KMB
|
+$253K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$1.58M |
| 2 |
Target
TGT
|
+$977K |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$916K |
| 4 |
Microsoft
MSFT
|
+$629K |
| 5 |
Apple
AAPL
|
+$554K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.03% |
| 2 | Financials | 15.75% |
| 3 | Consumer Staples | 14.4% |
| 4 | Technology | 14.21% |
| 5 | Industrials | 13.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.99T
| $9.3M | 4.61% |
70,103
-4,603
| -6% | -$554K |
|
|
2
Target
TGT
$65.5B
| $7.78M | 3.86% |
44,089
-5,860
| -12% | -$977K |
|
|
3
Microsoft
MSFT
$2.92T
| $7.09M | 3.51% |
31,864
-2,925
| -8% | -$629K |
|
4
Medtronic
MDT
$111B
| $7M | 3.47% |
59,742
-2,200
| -4% | -$242K |
|
5
Berkshire Hathaway Class B
BRK.B
$1.11T
| $6.49M | 3.22% |
27,986
-750
| -3% | -$165K |
|
6
Procter & Gamble
PG
$347B
| $5.7M | 2.82% |
40,962
-2,160
| -5% | -$302K |
|
7
Verizon
VZ
$201B
| $5.14M | 2.55% |
87,437
-268
| -0.3% | -$15.9K |
|
8
Federated Hermes
FHI
$4.59B
| $5.13M | 2.54% |
177,476
-14,320
| -7% | -$381K |
|
9
Intel
INTC
$435B
| $5.07M | 2.51% |
101,715
-6,090
| -6% | -$297K |
|
10
Comcast
CMCSA
$85.8B
| $4.94M | 2.45% |
94,370
-9,080
| -9% | -$435K |
|
11
Travelers Companies
TRV
$82.9B
| $4.83M | 2.39% |
34,429
-1,569
| -4% | -$201K |
|
|
BNY
12
Bank of New York Mellon
BNY
$106B
| $4.81M | 2.38% |
113,246
-7,600
| -6% | -$292K |
|
13
Autoliv
ALV
$9.09B
| $4.77M | 2.36% |
51,770
-4,610
| -8% | -$398K |
|
14
Emerson Electric
EMR
$85B
| $4.36M | 2.16% |
54,310
-4,265
| -7% | -$317K |
|
|
ABB
15
DELISTED
ABB Ltd
ABB
| $4.14M | 2.05% |
148,190
-14,750
| -9% | -$393K |
|
16
Corteva
CTVA
$59.5B
| $3.98M | 1.97% |
102,791
-6,150
| -6% | -$220K |
|
17
Walt Disney
DIS
$172B
| $3.65M | 1.81% |
20,140
-1,200
| -6% | -$172K |
|
18
UnitedHealth
UNH
$389B
| $3.45M | 1.71% |
9,852
-1,025
| -9% | -$344K |
|
|
19
Pfizer
PFE
$144B
| $3.41M | 1.69% |
92,592
+26,019
| +39% | +$954K |
|
20
Citigroup
C
$222B
| $3.25M | 1.61% |
52,672
-4,825
| -8% | -$245K |
|
21
United Parcel Service
UPS
$89.7B
| $3.23M | 1.6% |
19,174
-911
| -5% | -$154K |
|
22
Bio-Techne
TECH
$11.2B
| $3.04M | 1.51% |
38,260
-1,980
| -5% | -$143K |
|
|
23
Kimberly-Clark
KMB
$37.5B
| $3.02M | 1.5% |
22,380
+1,805
| +9% | +$253K |
|
24
Bank of America
BAC
$439B
| $2.98M | 1.48% |
98,354
-6,700
| -6% | -$180K |
|
25
Johnson & Johnson
JNJ
$643B
| $2.97M | 1.47% |
18,887
-455
| -2% | -$67.1K |
|
Similar funds
EA
GCM
PAM
HIS
MM
FCG
AWM
WI
Murphy Pohlad Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, Murphy Pohlad Asset Management held 104 positions worth $202M, up 7.2% from $188M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Murphy Pohlad Asset Management withdrew a net $12M in Q4 2020, closing 5 positions and reducing 59 holdings. Its most notable exit was Biogen, an estimated $1.58M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Staples.
Against the trend, Murphy Pohlad Asset Management opened a new position in Newell Brands worth $494K.
- Murphy Pohlad Asset Management's largest Q4 2020 buy was Newell Brands: 23,300 shares worth $494K.
- Murphy Pohlad Asset Management added most to Pfizer in Q4 2020, an estimated $954K increase.
- Murphy Pohlad Asset Management's biggest Q4 2020 reduction was Target, cutting an estimated $977K.
- Murphy Pohlad Asset Management fully exited Biogen in Q4 2020, selling an estimated $1.58M.
- Murphy Pohlad Asset Management's ten largest holdings make up 32% of its $202M portfolio in Q4 2020.
- Murphy Pohlad Asset Management opened 3 new positions and closed 5 in Q4 2020.
- Murphy Pohlad Asset Management's portfolio value rose 7.2% quarter-over-quarter to $202M.
Based on Murphy Pohlad Asset Management's 13F filing for Q4 2020, filed 5 Feb 2021.